Physician profile
Samer Bahu
NPI 1366547143
$5,752.12
in general payments reported to CMS, 2019-2025
21 companies · $1,254 in 2025
The $1,254 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $231 · 2021: $182 · 2022: $2,237 · 2023: $755 · 2024: $354 · 2025: $1,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,311 · Travel and Lodging: $51.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,311.21 |
| Travel and Lodging | $51.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,268.45 | 2019-2025 | Scopis Ent, Xpress Loprofile, Audion Et Dilation System |
| Medtronic, INC. | $333.13 | 2021-2024 | Propel |
| Abbvie INC. | $297.05 | 2023-2025 | Botox |
| Regeneron Healthcare Solutions, INC. | $280.43 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $207.50 | 2019-2020 | |
| Medtronic USA, INC. | $196.45 | 2019-2020 | |
| Ets Wound Care LLC | $188.44 | 2025 | Mirragen Advanced Wound Matrix |
| Aerin Medical INC. | $147.15 | 2019-2025 | |
| Axogen | $135.04 | 2025 | |
| Acclarent, INC | $127.40 | 2019-2023 | Acclarent Aera |
| Acera Surgical, INC. | $114.32 | 2025 | Restrata Wound Matrix |
| Checkpoint Surgical, INC | $96.84 | 2022 | |
| Glaxosmithkline, LLC. | $85.94 | 2022-2025 | Nucala |
| Genzyme Corporation | $59.86 | 2023-2024 | |
| Integra Lifesciences Corporation | $51.94 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jubilant Hollisterstier LLC | $47.87 | 2025 | |
| Merck Sharp & Dohme LLC | $32.99 | 2025 | Keytruda |
| Advanced Bionics, LLC | $23.56 | 2022 | |
| Mimedx Group, INC. | $21.83 | 2025 | |
| Optinose US, INC. | $19.23 | 2019 | |
| Ambu INC. | $16.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Bahu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.